# Study of FYU-981 in Hyperuricemia With or Without Gout

> **NCT02416167** · PHASE2 · COMPLETED · sponsor: **Fuji Yakuhin Co., Ltd.** · enrollment: 200 (estimated)

## Conditions studied

- Hyperuricemia

## Interventions

- **DRUG:** FYU-981
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02416167
- **Lead sponsor:** Fuji Yakuhin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02416167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02416167, "Study of FYU-981 in Hyperuricemia With or Without Gout". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02416167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*